Identificación de las competencias del gastroenterólogo chileno: técnica delphi modificada / Competencies of a chilean gastroeneterologist: modified delphi technique

Introduction: The importance of identifying the final competences of pre and postgraduate students is a growing a concern at national and international level due to the need of developing curricula aimed at educating competent professionals that respond to the society´s needs. Objetive: To identify the competencies of a general gastroenterologist (GG). Methods: Modified Delphi technique with a 3-round survey to a group of experts at national level. Sixty-eigth experts were surveyed including gastroenterologists, professionals of related specialties, representatives of scientific societies, and organizations that provide accreditation of both medical study programs and specialties certification. The first survey proposed a list of 224 competencies. Then, in the second and third rounds, the experts must prioritize the competencies according to the importance, usin a 0-4 Likert-type scale. Results: In the first round, 41 experts (60.3 percent) prioritized the 332 identified competencies. Og those, 255 were considered important or very important. In the third round, 252 competencies were confirmed as relevant by 38 experts (55.9 percent). Of the 49 practical procedures identified, only 15 were finally considered as part of the competencies of the GG.A significant percentage of procedures were considered of a higher level of training, particularly, complex endoscopic procedures. Conclusion: Identified competencies will be highly useful in the desing of competencies based curricula and in the implementation of evaluation systems appropriate for each competency. Specialty programs and their graduates might be evaluated according to these competencies.

Introducción: Identificar las competencias terminales de los egresados de pre y postgrado es de creciente interés nacional e internacional debido a la necesidad de desarrollar currículos enfocados en la formación de profesionales competentes, que respondan a las necesidades de la sociedad. El Gastroenterólogo General (GG), debe adquirir competencias cognitivas, destrezas psicomotrices y actitudes. Objetivo: Identificar las competencias del GG. Método: Encuesta de 3 rondas con técnica Delphi modificada a un grupo de expertos a nivel nacional para priorizar las competencias del GG según importancia utilizando una escala Likert de 0 a 4. Se encuestó a 68 expertos incluyendo gastroenterólogos, profesionales de especialidades relacionadas, representantes de Sociedades Científicas, organismos acreditadores de programas y certificadores de especialidades médicas. Resultado: En la primera ronda, se ofreció una lista de 224 competencias a 37 profesionales (54,4 por ciento del total de expertos) quienes agregaron 108 competencias adicionales. En la segunda ronda, 41 expertos (60,3 por ciento) priorizaron las 332 competencias identificadas. De ellas, 255 fueron consideradas importantes o muy importantes. En la tercera ronda, 252 competencias fueron confirmadas como relevantes por 38 expertos (55,9 por ciento). De los 49 procedimientos prácticos identificados, sólo 15 fueron finalmente considerados como parte de las competencias del GG. Un alto porcentaje de los procedimientos fueron considerados en un nivel de entrenamiento superior, en particular los procedimientos endoscópicos complejos. Conclusión: Las competencias identificadas serán de gran utilidad en el diseño de currículos basados en competencias e implementación de sistemas de evaluación apropiados para cada competencia. Los programas de especialidad así como sus egresados podrán ser evaluados de acuerdo a estas competencias.

[Etiology of febrile neutropenia episodes among cancer patients from Hospital Clinico Universidad Catolica, Santiago-Chile]. / Etiología de episodios de neutropenia febril en pacientes adultos con cáncer hematológico y de órganos sólidos en el Hospital Clínico Universidad Católica, Santiago-Chile.

INTRODUCTION: The surveillance of febrile neutropenia (FN) episodes in every center allows adapt the antibiotic therapy guidelines to local epidemiology. AIM: To characterize clinical features and compare the FN etiology between hematological cancer (HC) and solid organ cancer (SOC) in our center. PATIENTS AND METHODS: Surveillance study in adult patients with FN admitted to Hospital Clinico Universidad Católica, in Santiago, Chile, from January 2004 to August 2007. RESULTS: 154 FN episodes corresponding to 87 patients were included. Mean age: 47 +/- 6 years-old; 71% had HC and 29% SOC. A clinical and/or microbiologically documented infection was recognized in 76%. Gastrointestinal 31.5%, upper respiratory 30.3% and lower respiratory 16.9% were the more frequent clinical focus. In 30.5% blood culture resulted positive: gram negative rods 51%, gram positive cocci 41% and yeasts 8%; being Escherichia coli 22%, S. coagulase negative (SCoN) 20% and Klebsiella pneumoniae 12% most frequent bacteria; 22.2% Enterobacteriaceae were ESBL producers and 55.6% 5CoN were methicillin resistant. In 18.3% of FN episodes the etiology was not established. Highest mortality was observed in episodes with microbiologically documented infection (14.5% vs 1.3%, p < 0.005). A clinical observed focus and positive blood cultures were more frequently obtamed among HC than SOC associated episodes: 37.3% vs 13.6%; (p < 0.01) and 67.2% vs 50%; (p = 0.045), respectively. CONCLUSIONS: The etiological profile of FN in our center and the necessity to continue the surveillance was described. Future studies are needed regarding risk factors of invasive infection that have worst prognosis.

[Invasive fungal disease in hemato-oncological and hematopoietic stem cell transplantation patients from Hospital Clinico Universidad Católica, Santiago-Chile using revised EORTC/MSG diagnostic criteria]. / Enfermedad fúngica invasora en pacientes hemato-oncológicos y receptores de trasplante de precursores hematopoyéticos bajo la perspectiva de los criterios diagnósticos EORTC/MSG.

INTRODUCTION: Invasive fungal disease (IFD) is a severe complication occurring mostly in haematooncological (H-O) patients and hematopoietic stem cell transplant (HSCT) receptors. Our aim was to describe the IFD occurring in our H-O and HSCT patients according to the EORTC/MSG revised criteria. PATIENTS AND METHODS: IFD surveillance was performed in adult patients of the Hospital Clínico Universidad Catolica, Santiago, Chile, from January 2004 to January 2008. RESULTS: A total of 41 IFD episodes were identified in 39 patients; mean age was 46.6 +/- 9.9 years, and 87.8% and 12.2% occurred in H-O and HCTS patients respectively. 15/41(36.6%) episodes were proven, 36.6% probable and 11/41 (26.8%) possible. In 26 (63.4%) episodes aspergillosis was diagnosed (20 pulmonary, 3 sinus, 1 laryngeal and 1 case with pulmonary and cerebral involvement). In 7 patients (17.1%) candidiasis was diagnosed, 5 with a proven bloodstream infection and 2 with possible hepatosplenic candidiasis; mucormyeosis was diagnosed in 4 (9.8%) Fusarium infection was demonstrated in 2 patients (4.9%), and Mucor and Aspergillus pulmonary coinfection and Alternaria sp rhino-sinusitis in one patient each. The frequency of IFD among febrile neutropenic patients was 26.2% and 6.4% in H-O and HSCT receptors respectively. The overall mortality was 36%. CONCLUSIONS: Aspergillosis is the most common IFD infection among H-O patients and HSCT receptors in our center. Candidiasis followed although only in H-O patients most probably because of routine use of antifungal prophylaxis in HSCT recipients. Continuous surveillance is required to develop local guidelines and to evaluate antifungal strategies in different clinical scenarios.

Enfermedad fúngica invasora en pacientes hemato-oncológicos y receptores de trasplante de precursores hematopoyéticos bajo la perspectiva de los criterios diagnósticos EORTC/MSG / Invasive fungal disease in hemato-oncological and hematopoietic stem cell transplantation patients from Hospital Clinico Universidad Católica, Santiago-Chile using revised EORTC/MSG diagnostic criteria

Introduction: Invasive fungal disease (IFD) is a severe complication occurring mostly in haemato-oncological (H-O) patients and hematopoietic stem cell transplant (HSCT) receptors. Our aim was to describe the IFD occurring in our H-O and HSCT patients according to the EORTC/MSG revised criteria. Patients and Methods: IFD surveillance was performed in adult patients of the Hospital Clínico Universidad Católica, Santiago, Chile, from January 2004 to January 2008. Results: A total of 41 IFD episodes were identified in 39 patients; mean age was 46.6 ± 9.9 years, and 87.8 percent and 12.2 percent occurred in H-O and HCTS patients respectively. 15/41(36.6 percent) episodes were proven, 36.6 percent probable and 11/41 (26.8 percent) possible. In 26 (63.4 percent) episodes aspergillosis was diagnosed (20 pulmonary, 3 sinus, 1 laryngeal and 1 case with pulmonary and cerebral involvement). In 7 patients (17.1 percent) candidiasis was diagnosed, 5 with a proven bloodstream infection and 2 with possible hepatosplenic candidiasis; mucormyeosis was diagnosed in 4 (9.8 percent) Fusarium infection was demonstrated in 2 patients (4.9 percent), and Mucor and Aspergillus pulmonary coinfection and Alternaría sp rhino-sinusitis in one patient each. The frequency of IFD among febrile neutropenic patients was 26.2 percent and 6.4 percent in H-O and HSCT receptors respectively. The overall mortality was 36 percent. Conclusions: Aspergillosis is the most common IFD infection among H-O patients and HSCT receptors in our center. Candidiasis followed although only in H-O patients most probably because of routine use of antifungal prophylaxis in HSCT recipients. Continuous surveillance is required to develop local guidelines and to evaluate antifungal strategies in different clinical scenarios.

Introducción: La enfermedad fúngica invasora (EFI) es una complicación grave en pacientes hemato-oncológicos (H-O) y receptores de trasplante de precursores hematopoyéticos (TPH). Objetivo: Describir las EFI diagnosticadas en pacientes adultos H-O y receptores de TPH de nuestro centro, bajo los criterios diagnósticos revisados de EORTC/MSG. Pacientes y Métodos: Estudio de vigilancia de EFI en pacientes adultos del Hospital Clínico de la Pontificia Universidad Católica de Chile entre enero 2004 y enero 2008. Resultados: Se identificaron 41 episodios de EFI, correspondientes a 39 pacientes: 46,6 ± 9,9 años, 87,8 por ciento H-Oy 12,2 por ciento TPH. Se documentaron 15/41 (36,6 por ciento) EFI demostrada, 36,6 por ciento probable y 11/41 (26,8 por ciento) posible. En 26/41 (63,4 por cientoo) se diagnosticó aspergilosis (20 pulmonar, 3 rinosinusal, 1 laríngeo y un caso cerebral-pulmonar). En 7/41 (17,1 por ciento) se diagnosticó candidiasis, 5 candidemias y 2 candidiasis hepato-esplénica posibles; 4/41 (9,8 por cientoo) correspondió a mucormicosis demostrada (2 rinosinusal, 1 oral y 1 pulmonar); en 2/41 (4,9 por cientoo) fusariosis; 1/41(2,4 por ciento)) coinfección pulmonar por mucoral y Aspergillus sp y 1 caso de rinosinusitis por Alternaría sp. La frecuencia de EFI entre pacientes H-O con neutropenia febril fue 26,2 por ciento) y 6,4 por ciento) en los receptores de TPH. La mortalidad global fue de 36 por ciento). Conclusiones: Aspergilosis es la EFI más frecuente en H-O y receptores de TPH de nuestro centro. Candidiasis es la segunda EFI en frecuencia; sin embargo, no se documentó entre los pacientes receptores de TPH, lo que puede relacionarse al uso de antifúngicos profilácticos en este grupo. Es necesaria la vigilancia continua para desarrollar guías clínicas locales y evaluar estrategias de uso de antifúngicos en distintos escenarios clínicos.

Etiología de episodios de neutropenia febril en pacientes adultos con cáncer hematológico y de órganos sólidos en el Hospital Clínico Universidad Católica, Santiago-Chile / Etiology of febrile neutropenia episodes among cancer patients from Hospital Clinico Universidad Catolica, Santiago-Chile

Introduction: The surveillance of febrile neutropenia (FN) episodes in every center allows adapt the antibiotic therapy guidelines to local epidemiology. Aim: To characterize clinical features and compare the FN etiology between hematological cáncer (HC) and solid organ cancer (SOC) in our center. Patients and Methods: Surveillance study in adult patients with FN admitted to Hospital Clinico Universidad Católica, in Santiago, Chile, from January 2004 to August 2007. Results: 154 FN episodes corresponding to 87 patients were included. Mean age: 47 ± 6 years-old; 71 percent had HC and 29 percent SOC. A clinical and/or microbiologically documented infection was recognized in 76 percent. Gastrointestinal 31.5 percent, upper respiratory 30.3 percent and lower respiratory 16.9 percent were the more frequent clinical focus. In 30.5 percent blood culture resulted positive: gram negative rods 51 percent, gram positive cocci 41 percent and yeasts 8 percent; being Escherichia coli 22 percent, S. coagulase negative (SCoN) 20 percent and Klebsiella pneumoniae 12 percent most frequent bacteria; 22.2 percent Enterobacteriaceae were ESBL producers and 55.6 percent 5CoN were methicillin resistant. In 18.3 percent of FN episodes the etiology was not established. Highest mortality was observed in episodes with microbiologically documented infection (14.5 percent vs 1.3 percent, p < 0.005). A clinical observed focus and positive blood cultures were more frequently obtamed among HC than SOC associated episodes: 37.3 percent vs 13.6 percent; (p < 0.01) and 67.2 percent vs 50 percent; (p = 0.045), respectively. Conclusions: The etiological profile of FN in our center and the necessity to continue the surveillance was described. Future studies are needed regarding risk factors of invasive infection that have worst prognosis.

Introducción: La vigilancia de la etiología de los episodios de neutropenia febril (NF) en cada centro permite adaptar guías de antibioterapia a la epidemiología local. Objetivo: Caracterizar y comparar la etiología de la NF en pacientes con cáncer hematológico (CH) y de órganos sólidos (COS). Pacientes y Métodos: Estudio de vigilancia de NF de pacientes adultos en el Hospital Clínico Universidad Católica, en Santiago, Chile, entre enero 2004 y agosto 2007. Resultados: 154 episodios de NF correspondientes a 87 pacientes: 47 ± 6 años; 71 por ciento CH y 29 por ciento COS. Se documentó infección clínica y/o microbiológicamente en 76 por cientoo. Más frecuente fueron: foco gastrointestinal 31,5 por ciento, respiratorio alto 30,3 por cientoo y respiratorio bajo 16,9 por cientoo. En 30,5 por cientoo hubo hemocultivos positivos: bacilos gramne-gativos en 51 por ciento, cocáceas grampositivas en 41 por ciento, levaduras en 8 por cientoo; predominando: Escherichia coli 22 por cientoo, Staphylococcus coagulasa negativa (SCoN) 20 por cientoo y Klebsiella pneumoniae 12 por ciento; 22,2 por cientoo de las entero-bacterias eran productoras de (3-lactamasa de espectro expandido y 55,6 por cientoo >SCoN meticilina resistentes. En 18,3 por cientoo de los episodios no se identificó causa de fiebre. Hubo mayor mortalidad en episodios con documentación microbiológica (14,5 por ciento vs 1,3 por ciento, p < 0,005). En los pacientes con CH fue más frecuente obtener hemocultivos positivos (37,3 por cientoo vs 13,6 por ciento; p < 0,01) e identificar foco clínico (67,2 por ciento vs 50 por ciento; p = 0,045). Conclusiones: Se establece el perfil etiológico de las NF en nuestro centro y la necesidad de mantener vigilancia. En futuros estudios será necesario evaluar factores de riesgo de pacientes con infecciones invasores que tendrían peor pronóstico.

[Usefulness of the determination of IgG and IgM antibodies by ELISA and immunocapture in a clinical series of human brucellosis]. / Utilidad de la determinación de anticuerpos IgG e IgM por ELISA e inmunocaptura en una serie clínica de brucelosis humana.

INTRODUCTION: The diagnostic difficulties of brucellosis makes the evaluation of new diagnostic tests necessary. OBJECTIVES: Evaluation of different commercial tests in the serological diagnosis of brucellosis by ELISA and immunocapture antibodies in a clinical series of patients with brucellosis of the Health Network of the Catholic University of Chile. METHODS: All the serums received in the Laboratory of Microbiology for suspicion of brucellosis during five years were studied. Two groups were obtained, one that fulfilled diagnostic criteria for brucellosis [clinical evidence, and/or positive blood culture and/or seroagglutination test (SAT) in titers > 1/160] and the control group. Each serum sample was analyzed using irnmunocapture-agglutination test (Brucellacapt), ELISA IgM and IgG. RESULTS: Of 10 patients with brucellosis, the serologic results were: 8/10 positives for ELISA IgG, 7/10 for Brucellacapt and SAT, and 5/10 for ELISA IgM. DISCUSSION: ELISA IgG alone was superior than SAT. The combination ELISA IgG/ Brucellacapt reaches the best detection performance (9/10) and can be an alternative to SAT.

Cánceres de cavidades paranasales / Paranasal sinuses cancers

Los cánceres de la cavidad nasal y de las cavidades paranasales (CPN) son neoplasias infrecuentes y de una gran variedad histológica. La complejidad de las estructuras vitales circundantes hacen que la cirugía radical y la radioterapia se asocien a complicaciones. Publicaciones recientes sobre el tema han demostrado una mejoría progresiva tanto de los métodos terapéuticos como de los resultados postratamiento. Repasamos los tipos de neoplasias que ocurren en las CPN y se discuten las opciones de tratamiento actuales, incluyendo las técnicas quirúrgicas y la terapia multimodal. Las neoplasias de CPN son complejas de tratar debido a las características anatómicas de la región y a la variedad de cánceres que ocurren en esta área. Actualmente el gold standard es la cirugía, abierta o endoscópica, combinada con radioterapia adyuvante. Las complicaciones potenciales incluyen cefalorraquia, meningitis, la formación de abscesos, ceguera, entre otros. Para mejorar la sobrevida de los pacientes con cáncer, debemos centrarnos en el diagnóstico precoz y preciso, así como en la búsqueda de tratamientos más eficaces, con los menores efectos adversos.

Cancers of the nasal cavity and paranasal sinuses are infrequent and of a great variety of histological types. The complexity of the surrounding vital structures render radical surgery and radiation therapy delicate and associated with numerous complications. Recent papers on nasal and paranasal sinuses carcinomas have shown a progressive improvement of treatments and results. Here we review paranasal sinuses tumor types and discuss current treatment options, including surgical techniques and polimodal therapy. Paranasal sinuses treatment is complex, because of the anatomic details of the region and the variety of cancers found in this area. At present, the gold standard is open or transnasal surgery, combined with adjuvant radiation therapy. Potential complications include cerebrospinal fluid leakage, meningitis, abscess formation and blindness, among others. in order to improve the survival of cancer patients, we should focus on early and accurate diagnosis as well as in the search for more effective treatments that minimize undesired side effects.

Utilidad de la determinación de anticuerpos IgG e IgM por ELISA e inmunocaptura en una serie clínica de brucelosis humana / Usefulness of the determination of IgG and IgM antibodies by ELISA and immunocapture in a clinical series of human brucellosis

Introducción: El diagnóstico de brucelosis continúa siendo complejo en la actualidad y se requieren nuevas pruebas de diagnóstico. Objetivo: Evaluar pruebas comerciales para la determinación serológica de anticuerpos anti Brucella sp mediante ELISA e inmunocaptura en una serie clínica de pacientes de la Red de Salud UC. Métodos: Estudio retrospectivo de pacientes cuyos sueros fueron recibidos en el laboratorio de Microbiología para estudio serológico de brucelosis. Se obtuvieron 2 grupos, aquellos que cumplían criterios diagnósticos de brucelosis [cuadro clínico compatible, y/o hemocultivo positivo y/o serología por seroaglutinación en tubo (SAT) en títulos > 1/160] y el grupo control. Todos los sueros se analizaron mediante aglutinación con inmunocaptura (Brucellacapt®), ELISA IgM y ELISA IgG. Resultados: De 10 pacientes con brucelosis, los resultados serológicos fueron: 8/10 positivos para ELISA IgG, 7/10 para Brucellacapt® y SAT y 5/10 para ELISA IgM. Discusión: ELISA IgG por si solo fue la mejor prueba para el diagnóstico de brucelosis. La combinación ELISA IgG+ Brucellacapt® alcanza un buen rendimiento de detección (9/10) y puede ser una alternativa a la SAT.

Introduction: The diagnostic difficulties of brucellosis makes the evaluation of new diagnostic tests necessary. Objectives: Evaluation of different commercial tests in the serological diagnosis of brucellosis by ELISA and immunocapture antibodies in a clinical series of patients with brucellosis of the Health Network of the Catholic University of Chile. Methods: All the serums received in the Laboratory of Microbiology for suspicion of brucellosis during five years were studied. Two groups were obtained, one that fulfilled diagnostic criteria for brucellosis [clinical evidence, and/or positive blood culture and/or seroagglutination test (SAT) in titers > 1/160] and the control group. Each serum sample was analyzed using irnmunocapture-agglutination test (Brucellacapt®), ELISA IgM and IgG. Results: Of 10 patients with brucellosis, the serologic results were: 8/10 positives for ELISA IgG, 7/10 for Brucellacapt® and SAT, and 5/10 for ELISA IgM. Discussion: ELISA IgG alone was superior than SAT. The combination ELISA IgG/ Brucellacapt® reaches the best detection performance (9/10) and can be an alternative to SAT.